Please login to the form below

Not currently logged in
Email:
Password:

obesity

This page shows the latest obesity news and features for those working in and with pharma, biotech and healthcare.

Roche enters NASH race with deal to buy Jecure

Roche enters NASH race with deal to buy Jecure

Rates of NASH are rising thanks to an increase in obesity and diabetes, which increase the risk of developing the disease, and with improvements in the treatment of viral hepatitis is

Latest news

More from news
Approximately 39 fully matching, plus 311 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 28 partially matching documents found.

Latest appointments

  • Novo Nordisk appoints new senior principal clinical scientist Novo Nordisk appoints new senior principal clinical scientist

    Gough will be responsible for providing clinical guidance on the development of new molecules and drugs from early stage through to phase III and beyond for obesity and diabetes.

  • MedImmune appoints Dr Christopher Rhodes MedImmune appoints Dr Christopher Rhodes

    In that position he led a large team of researchers focused on molecular mechanisms that control key functions in the pathogenesis of diabetes and obesity.

  • Anthony Zook resigns as Vivus CEO Anthony Zook resigns as Vivus CEO

    shareholders became unhappy with the way Vivus handled the launch of its obesity drug Qsymia (phentermine/ topiramat). ... This coup was led by investment group First Manhattan Co, which had attempted to replace the entire board of Vivus after Qsymia

  • Roche’s Torsten Hoffmann to join Zealand Pharma Roche’s Torsten Hoffmann to join Zealand Pharma

    In his new role at Zealand, Dr Hoffmann joins a more compact company focused on the discovery of drugs in cardio-metabolic diseases, diabetes and obesity.

  • Burson-Marsteller hires senior DH press officer Burson-Marsteller hires senior DH press officer

    In her previous role, Moore worked with both public health ministers and the chief medical officer, developing proactive and reactive communications strategies for issues including immunisation, genetics, obesity and alcohol.

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 22 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics